Upregulation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1a) was also seen in breast cancer CTCs, leading to increased oxidative phosphorylation and ROS balance [208] (Figure 2B). Here, PPARGC1A is linked to breast carcinoma.